Profile: Nucryst Pharmaceuticals develops, manufactures and commercializes medical products that fight infection & inflammation based on its nanocrystalline silver technology. Our Acticoat™ dressings with Silcryst™ nanocrystals have demonstrated a broad antimicrobial spectrum and kill rate in vitro studies, inhibiting a wide range of pathogens. It includes drug-resistant bacteria such as methicillin-resistant staphylococcus aureus (MRSA) and vancomycin resistant enteroccocus.